Applied Molecular Transport AMTI Stock
Applied Molecular Transport Price Chart
Applied Molecular Transport AMTI Financial and Trading Overview
| Applied Molecular Transport stock price | 0.26 USD |
| Previous Close | 0.34 USD |
| Open | 0.29 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 900 |
| Day's Range | 0.29 - 0.32 USD |
| 52 Week Range | 0.21 - 3.95 USD |
| Volume | 134.34K USD |
| Avg. Volume | 223.58K USD |
| Market Cap | 12.23M USD |
| Beta (5Y Monthly) | 1.980306 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 0.6 USD |
AMTI Valuation Measures
| Enterprise Value | 6.26M USD |
| Trailing P/E | N/A |
| Forward P/E | -0.35340908 |
| PEG Ratio (5 yr expected) | -0.01 |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.3373102 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.064 |
Trading Information
Applied Molecular Transport Stock Price History
| Beta (5Y Monthly) | 1.980306 |
| 52-Week Change | -89.23% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3.95 USD |
| 52 Week Low | 0.21 USD |
| 50-Day Moving Average | 0.28 USD |
| 200-Day Moving Average | 0.69 USD |
AMTI Share Statistics
| Avg. Volume (3 month) | 223.58K USD |
| Avg. Daily Volume (10-Days) | 735.6K USD |
| Shares Outstanding | 39.34M |
| Float | 25.43M |
| Short Ratio | 2.99 |
| % Held by Insiders | 22.61% |
| % Held by Institutions | 47.82% |
| Shares Short | 359.02K |
| Short % of Float | 1.65% |
| Short % of Shares Outstanding | 0.91% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -47.68% |
| Return on Equity (ttm) | -136.18% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -42075000 USD |
| EBITDA | -98165000 USD |
| Net Income Avi to Common (ttm) | -111667000 USD |
| Diluted EPS (ttm) | -3.5 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 41.77M USD |
| Total Cash Per Share (mrq) | 1.06 USD |
| Total Debt (mrq) | 35.05M USD |
| Total Debt/Equity (mrq) | 96.96 USD |
| Current Ratio (mrq) | 2.754 |
| Book Value Per Share (mrq) | 0.922 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -82067000 USD |
| Levered Free Cash Flow (ttm) | -43733752 USD |
Profile of Applied Molecular Transport
| Country | United States |
| State | CA |
| City | South San Francisco |
| Address | 450 East Jamie Court |
| ZIP | 94080 |
| Phone | 650 392 0420 |
| Website | https://www.appliedmt.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 15 |
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of rhIL-10 that is in Phase II clinical trials to treat patients with chronic pouchitis, as well as is in Phase II development to treat patients with rheumatoid arthritis. It develops AMT-126, a GI-selective oral fusion of interleukin 22, which is in a Phase I clinical trial for diseases related to intestinal epithelium barrier function defects. The company, through its technology platform, designs and develops various oral and respiratory biologic therapeutic modalities, such as peptides, proteins, antibodies, antibody fragments, and ribonucleic acid therapeutics. Applied Molecular Transport Inc. was founded in 2010 and is headquartered in South San Francisco, California.
Q&A For Applied Molecular Transport Stock
What is a current AMTI stock price?
Applied Molecular Transport AMTI stock price today per share is 0.26 USD.
How to purchase Applied Molecular Transport stock?
You can buy AMTI shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Applied Molecular Transport?
The stock symbol or ticker of Applied Molecular Transport is AMTI.
Which industry does the Applied Molecular Transport company belong to?
The Applied Molecular Transport industry is Biotechnology.
How many shares does Applied Molecular Transport have in circulation?
The max supply of Applied Molecular Transport shares is 41.85M.
What is Applied Molecular Transport Price to Earnings Ratio (PE Ratio)?
Applied Molecular Transport PE Ratio is 0.00000000 now.
What was Applied Molecular Transport earnings per share over the trailing 12 months (TTM)?
Applied Molecular Transport EPS is 0 USD over the trailing 12 months.
Which sector does the Applied Molecular Transport company belong to?
The Applied Molecular Transport sector is Healthcare.
Applied Molecular Transport AMTI included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 15587.79 USD — |
-5.82
|
9.14B USD — | 15575.68 USD — | 16128.16 USD — | — - | 9.14B USD — |
| NASDAQ Global Select Market Com NQGS | 7625.89 USD — |
-5.84
|
— — | 7621.56 USD — | 7894.21 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 3904.12 USD — |
-5.49
|
— — | 3901.51 USD — | 4064.61 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 869.8 USD — |
-5.51
|
— — | 868.74 USD — | 900.72 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4153.28 USD — |
+1.21
|
— — | 4281.91 USD — | 4648.11 USD — | — - | — — |
- {{ link.label }} {{link}}